Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Drug Policies .

Tecelra® (afamitresgene autoleucel)

Niktimvoâ„¢ (axatilimab-csfr)

Acthar Gel, Cortrophin Gel

Aloxi

Benlysta

Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu

Cerezyme® (imiglucerase)

Aralast NP; Glassia; Prolastin-C; Zemaira

Lucentis, Byooviz, Cimerli

Elelyso

Sandostatin LAR

Synagis® (Palivizumab)

Trelstar

VPRIV

Xolair

Zoladex

Neulasta, Fulphila, Udenyca, Ziextenzo, Nyvepria; Fylnetra, Stimufend, Rolvedon, Ryzneuta

Leukine

Brineura

Beovu